1) Abciximab
Abciximab
2) Abciximab
阿昔单抗
3) Abciximab(ReoPro)
血小板GPⅡb/Ⅲa受体拮抗剂ReoPro
4) Cetuximab
西妥昔单抗
1.
Evaluation of Cetuximab in combination with radiotherapy or chemotherapy against advanced squamous cell carcinoma of the head and neck;
西妥昔单抗联合化疗或放疗治疗晚期头颈鳞癌的疗效评价(英文)
2.
Effects of Cetuximab Combined Erlotinib on Proliferation of Human Hepatocellular Carcinoma Cell Lines HepG2 and Bel-7402;
西妥昔单抗联合厄洛替尼对人肝癌细胞的体外抑制作用
3.
Clinical observation of combination chemotherapy for metastatic colorectal cancer with Cetuximab;
西妥昔单抗联合化疗治疗转移性结直肠癌的临床观察
5) cetuximab
cetuximab
1.
In this article the pharmacokenetics and clinical study of 3 anti-EGFR monoclonal antibodies (cetuximab, panitumumab and nimotuzomab) were reviewed.
本文对3种抗EGFR单克隆抗体(cetuximab,panitumumab和nimotuzomab)的药代动力学及其应用研究进行了综述。
6) cetuximab
西昔妥单抗
参考词条
Infliximab
infliximab
Infliximab
Rituximab
Rituximab
Rituximab
IT-Rituximab
rituximab
rituximab
Cetuximab(C225)
Cetuximab (C225)
Metuximab monoclonal antibody injection
rituximab treatment
Rituximab/therapeutic application
~ 99 Tc~m-IT-Rituximab
Rituximab/therapeutic application
monoclonal antibody Rituximab
生物标志物浓度
补充资料:昔留昔零
1.象声词。形容风雨等的飘打声。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。